Atea Pharmaceuticals Inc.
World Rank (Jan-05-2024)
16,476
Market Cap (Jan-05-2024)
0.264 Billion USD
World Rank (Jul-30-2023)
16,155
Market Cap (Jul-30-2023)
0.284 Billion USD
World Rank (Dec-25-2022)
14,183
Market Cap (Dec-25-2022)
0.382 Billion USD
World Rank (Jan-07-2022)
11,890
Market Cap (Jan-07-2022)
0.64 Billion USD
Annual Revenue in USD
351 Million USD
Annual Net Income in USD
121 Million USD
Annual Results for Period Ending
Dec-2021 ending year
Company Profile
Atea is a Clinical Stage Biopharmaceutical company. It is focused on discovering, developing and commercializing therapies to address the unmet medical needs of patients with life threatening viral diseases. The company annual revenue is 13.6 million USD and 6,904 employees as on 2019. The headquarters is in USA.
Company Website